CSIMarket
 
Sotera Health Company  (SHC)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $14.5200 $0.34 2.398%
Day's High: $14.55 Week Perf: 3.71 %
Day's Low: $ 13.99 30 Day Perf: -12.9 %
Volume (M): 3,240 52 Wk High: $ 19.40
Volume (M$): $ 47,038 52 Wk Avg: $15.66
Open: $14.15 52 Wk Low: $12.34



 Market Capitalization (Millions $) 4,144
 Shares Outstanding (Millions) 285
 Employees 6,300
 Revenues (TTM) (Millions $) 1,049
 Net Income (TTM) (Millions $) 51
 Cash Flow (TTM) (Millions $) -95
 Capital Exp. (TTM) (Millions $) 215

Sotera Health Company
Sotera Health is a leading global provider of critical solutions for the healthcare industry.
The company was founded in 2015 and is headquartered in Broadview Heights, Ohio, US.
Sotera Health services a wide range of industries including medical device, pharmaceutical, tissue and implant industries.
Sotera Health operates through three primary business segments: Sterigenics, Nordion, and Nelson Labs.
Sterigenics is a leading provider of contract sterilization services for medical devices and pharmaceutical products.
Sterigenics operates through multiple facilities in North America, Europe, and Asia.
Nordion is a leading supplier of Cobalt-60, a radioactive isotope used in the sterilization of medical equipment and supplies.
Nordion is the only supplier of Cobalt-60 to the global market, supplying over 70% of the world's needs.
Nelson Labs is a leading provider of testing and consulting services for the medical device and pharmaceutical industries.
The company provides microbiology and analytical chemistry testing, biocompatibility testing, and toxicology consulting services, among others.
Sotera Health's mission is to provide safe, effective, and innovative solutions to support the healthcare industry in improving patient outcomes.
The company is committed to high standards of quality, safety, and compliance across all of its operations.
Sotera Health has a global presence with operations in more than 50 countries.
The company employs over 2,800 team members worldwide.
Sotera Health is also committed to sustainability and corporate responsibility.
The company has implemented various programs to reduce its environmental impact and promote social responsibility, including reducing carbon emissions, waste reduction, and community outreach initiatives.
Overall, Sotera Health is a leading provider of critical solutions for the healthcare industry, offering a wide range of services that support the development and delivery of safe and effective medical products.
The company's dedication to quality, safety, and compliance, as well as its commitment to sustainability and corporate responsibility, make it a trusted partner for healthcare companies worldwide.


   Company Address: 9100 South Hills Blvd Broadview Heights 44147 OH
   Company Phone Number: 262-1410   Stock Exchange / Ticker: NASDAQ SHC
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Sotera Health Company

Headline: Sotera Health Company Achieves Impressive Financial Results in 2023

The financial results of Sotera Health Company for the fourth quarter and full-year 2023 are quite impressive, showing strong revenue growth and a significant improvement in profitability. The company reported a 23.612% increase in revenue to $311.00 million, leading to earnings per share of $0.13 compared to a loss of $1.14 per share in the same period last year. The company also saw a sequential increase in income per share from a loss of $0.05 per share and a growth in revenue of 18.257% from the previous quarter.
The most notable achievement for Sotera Health Company was turning a net income of $38.681 million in the fourth quarter of 2023, a significant improvement from a net loss of $319.719 million in the same quarter a year ago. The company also highlighted its improving profit margins, with a net margin of 12.44% and an operating margin of 33.45% in the fiscal year ending December 31, 2023. This is a positive sign for investors as it indicates that the company is effectively managing its costs and increasing its profitability.

Financing Agreement

Sotera Health Company Sets New Course with Secondary Offering of Common Stock

Published Tue, Feb 27 2024 10:30 PM UTC

Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, Feb. 27, 2024 - Sotera Health Company has recently launched a secondary offering of 25,000,000 shares of its common stock. The shares are being offered for sale by selling stockholders, including affiliates of Warburg Pincus LLC and GTCR, LLC, as well as two members of management and one member of the ...

Sotera Health Company

Sotera Health Company Faces $14.13 Million Tax Charge Amidst Positive Growth Trends2.

Over the past week, the stock of Sotera Health Company (SHC) experienced a decline of -3.07%. This brings the year-to-date performance to a positive growth of 51.38%. Despite this positive growth, the stock is currently trading on the NASDAQ at a value that is -14.5% below its 52-week average. So, what factors have contributed to these numbers?
During the third quarter of 2023 earnings season, SHC reported a deficit of $-0.05 per share, which is a significant decrease compared to the $0.09 per share profit it had in the same period the previous year. Additionally, the income per share fell from $0.08 per share in the prior reporting period. Although these numbers indicate a decline in profitability, there was growth in the company's revenue. It increased by 5.742% to $262.98 million compared to $248.70 million in the corresponding reporting period a year prior. Sequentially, the revenue also advanced by 3.298% from $254.59 million.
Despite the revenue growth, SHC's top-line gain lagged behind its peers in the Healthcare Facilities sector, as it only experienced a 7.13% increase relative to the Q3 of 2022 top-line rise. Another significant change was the net deficit of $-13.660 million logged during the third quarter of 2023, compared to net proceeds of $25.090 million in the same reporting period the previous year. However, it's important to note that excluding a $14.13 million tax charge, there would have been a net profit for this earnings season.

Sotera Health Company

Sotera Health Company Reports a 4.52% Dip in Revenue for Q2 2023 Yet Shows Major Improvement in EPS

In the period from April to June 2023, Sotera Health Company (SHC) experienced a decline in income per share of -27.27%, dropping from $0.11 per share to $0.08 per share compared to the previous year. However, there was a significant improvement in the earnings per share (EPS) of 700%, rising from $0.01 per share in the preceding reporting season.
The company's revenue also contracted by -4.52% to $254.59 million from $266.64 million in the same reporting season a year prior. However, there was a sequential revenue improvement of 15.412% from $220.59 million. It is important to note that this decline in top-line revenue is in contrast to the rest of the Healthcare Facilities industry, which recorded an improvement in revenue during the same time period.
Sotera Health Company's bottom-line also decreased by -22.7% to $23.513 million in the April to June 2023 interval, compared to $30.418 million in the corresponding period the year before. Despite this decrease, the company's operating margin still stood at 24.83%, and the net margin shrank to 9.24%.
The company's inventories have declined to $42.1 million from the previous quarter, although this marks an increase compared to the same period a year ago. Operating earnings fell by -11.6% to $63.204 million, leading to a decrease in Sotera Health Company's operating margin to 24.83% from 26.81% in the second quarter of 2022.
Moreover, the value of accounts receivable is still below the previous year's level, but there has been some progress sequentially. Sotera Health Company is expected to report its next financial numbers on November 01, 2023.
In terms of the company's stock performance, over the last five trading days, Sotera Health Company shares have dropped by -2.25%, bringing the year-to-date performance to 124.49%. The shares are currently 8.4% below the 52-week high.

Sotera Health Company

revenue receded by -6.827 %, at the company in the most recent fiscal period

Sotera Health Company, a leading provider of sterilization and lab testing services in the healthcare industry, recently reported a cumulative net loss of $-261 million during the 12 months ending in the first quarter of 2023. This has resulted in a negative return on equity (ROE) of -53.5%, indicating that the company's profitability has declined significantly over the past year.
In comparison to its competitors in the healthcare facilities industry, Sotera Health Company ranks low in terms of its return on equity. Eight other companies within the industry have reported higher ROE numbers, which suggests that Sotera Health Company needs to reassess its strategies to improve its financial performance.






 

Sotera Health's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Sotera Health does not provide revenue guidance.

Earnings Outlook
Sotera Health Company does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com